NCT01010217 2020-03-25
Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide
M.D. Anderson Cancer Center
Phase 2 Completed
M.D. Anderson Cancer Center
National Heart, Lung, and Blood Institute (NHLBI)
M.D. Anderson Cancer Center
Duke University